Print preview Close
Showing 679 results
Archival description![[E] Parliament Hansard of the debate on UK Microbeads ban](/uploads/r/null/f/9/0/f906d55b45c955f363670743d48b5ef92c7a9a54963a1cb3fe5b4ab6583601c9/f1ad8483-c135-48c7-a221-9209d49a9dfe-_E__Environmental_Protection__Microbeads___England__Regulations_2017_-_Hansard_142.jpg)
[E] Parliament Hansard of the debate on UK Microbeads ban
![[E] Oral Evidence on Quantum Technologies at Science and Technology Committee](/uploads/r/null/b/b/6/bb634f47c322440ef097ddccfa63f95f0cc9a2fd921e0dc1d3801ff8a2c797a5/8ff975c4-39c0-40de-9ed2-d652329b1153-_E__Oral_evidence_-_Quantum_technologies_-_5_Jun_2018_142.jpg)
[E] Oral Evidence on Quantum Technologies at Science and Technology Committee
![[E] Online post featuring WinBUGS](/uploads/r/null/7/e/e/7eef4c125b9fed1a879c0bac2ff08c24eea4dd4b7eeae792b5a09801b3a0f152/122e14c6-ffaf-49d9-9827-d79f801d2b87-_E__screencapture-elevanth-org-blog-2017-11-28-build-a-better-markov-chain-2021-02-26-12_07_46_142.jpg)
[E] Online post featuring WinBUGS
![[E] Nightstar therapeutics raises 75 million in ipo to fund pivotal phase 3 gene therapy study.pdf](/uploads/r/null/9/d/7/9d793c1bdc0455861ba08524778bb7e9e09ccc9ed7bed37d41bca0ee2d5345b0/310ef8d8-4513-46a0-b732-4dce579b0a35-_E__Nightstar_therapeutics_raises_75_million_in_ipo_to_fund_pivotal_phase_3_gene_therapy_study_142.jpg)
[E] Nightstar therapeutics raises 75 million in ipo to fund pivotal phase 3 gene therapy study.pdf
![[E] NHS England Specialist Commissioning guidance Lung volume reduction by surgery or endobronchial valve for severe emphysema in adults.pdf](/uploads/r/null/6/5/0/65076b7c0849f0c0189a18b39d622f8c5f226e0f2174c0a89619ea0ce428ae39/9fa6c55e-43be-4475-81f1-545d6d18480f-_E__NHS_England_Specialist_Commissioning_guidance_Lung_volume_reduction_by_surgery_or_endobronchial_valve_for_severe_emphysema_in_adults_142.jpg)
[E] NHS England Specialist Commissioning guidance Lung volume reduction by surgery or endobronchial valve for severe emphysema in adults.pdf
![[E] Negative emissions pioneer Drax announces new CCUS projects during Energy Minister’s visit](/uploads/r/null/e/8/4/e844cade4ec6bb2c4e020c733d0818adace426c341645cc78a6a68618b862c38/f7fccf9f-a0aa-4852-8b11-6ca69960e91b-_E__drax-press-release_2020-10-13-14_50_49_142.jpg)
[E] Negative emissions pioneer Drax announces new CCUS projects during Energy Minister’s visit
![[E] National Strategy to Climate Change Adaptation (NSACC)](/uploads/r/null/a/4/c/a4c9383494ea7b368ac9890f1580eb1e69c033f3a6bb43a1decf33769af1de0b/5aa36dda-d3ef-4680-a446-a9725d445a12-_E__NSACC_142.jpg)
[E] National Strategy to Climate Change Adaptation (NSACC)
![[E] Minutes of the sixtieth SAGE meeting on Covid-19. 1 Oct 2020 reference to data from REACT-1 in Point 12. .pdf](/uploads/r/null/a/0/f/a0f7e49be65ca9c2bfcc863cac50038c3e8d50ae62c5280926c74ca432cfa08e/134637be-52e5-4c1f-af99-497df80db26f-_E__Minutes_of_the_sixtieth_SAGE_meeting_on_Covid-19._1_Oct_2020_reference_to_data_from_REACT-1_in_Point_12.__142.jpg)
[E] Minutes of the sixtieth SAGE meeting on Covid-19. 1 Oct 2020 reference to data from REACT-1 in Point 12. .pdf
![[E] Materials Studio Catalog](/uploads/r/null/b/1/1/b11a3625a7596d48a244a619403501c2706118f19b8c9bf7af8d5093b8a9b31d/e74a0671-3b5e-40bd-96e5-9c09f29745c6-_E__Materials_Studio_Course_Catalog-biovia_142.jpg)
[E] Materials Studio Catalog
![[E] Kentech Instruments Ltd. FLIM](/uploads/r/null/3/4/7/347d6adbc8b254eacbe9f622fa07e4e8dd58547e02914d3f448be72dac757772/5ae144bc-8634-4b07-a9aa-dcb6f7f34fef-_E__Kentech_instruments_7_4_2020_14_41_142.jpg)
[E] Kentech Instruments Ltd. FLIM
![[E] Hansard from the Lords debate on invasive species regulation](/uploads/r/null/0/d/e/0dee3b4679150cfd7406d72fbf437a046ad124c9d892de08a59f94ee31a8ee88/e0bf152b-de6a-43e1-a2c8-41eb65879f2c-_E__Invasive_Non-native_Species__Amendment_etc.___EU_Exit__Regulations_2019_-_Tuesday_22_January_2019_-_Hansard_-_UK_Parliament_142.jpg)
[E] Hansard from the Lords debate on invasive species regulation
![[E] Gripable.pdf](/uploads/r/null/e/0/f/e0f64843ce268f456826f2649f1e7a53fd8aa410733049cbb01e40764bbf7dd1/3860ccf0-46fb-4b5c-8b13-74614a09e3e2-_E__Gripable_142.jpg)
[E] Gripable.pdf
![[E] government news roll out of 2 new rapid coronavirus tests ahead of winter .pdf](/uploads/r/null/4/b/9/4b9efe17a198dd9745c6d70da3ba9a13b1f51dde03faefaed536c08584052300/3db5ecbb-9b37-42df-bca1-7aa9cd53cc11-_E__government_news_roll_out_of_2_new_rapid_coronavirus_tests_ahead_of_winter__142.jpg)
[E] government news roll out of 2 new rapid coronavirus tests ahead of winter .pdf
![[E] GAVI (2018). Hepatitis B Birth Dose Investment Case at the Vaccine Investment Strategy Programme and Policy Committee Meeting.pdf](/uploads/r/null/2/2/3/223cc631a390e6131663fccb2f7324349020e413ed2eb03c6339afac6755ba71/73fc26c1-1c1c-40fd-a61e-a7cf48f3c67d-_E__GAVI__2018_._Hepatitis_B_Birth_Dose_Investment_Case_at_the_Vaccine_Investment_Strategy_Programme_and_Policy_Committee_Meeting_142.jpg)
[E] GAVI (2018). Hepatitis B Birth Dose Investment Case at the Vaccine Investment Strategy Programme and Policy Committee Meeting.pdf
![[E] Funding to Vidya Health for Saliva Diagnostics. NHS Health Research Authority.](/uploads/r/null/2/8/5/2850997dbc1a7c6f00e426fda5c34b7e9a97045a57eed4f5e252217895ad0e66/451f1af3-c518-4ac8-9e12-9fc4f903103e-_E__screencapture-hra-nhs-uk-planning-and-improving-research-application-summaries-research-summaries-saliva-diagnostics-2021-03-02-09_59_54_142.jpg)
[E] Funding to Vidya Health for Saliva Diagnostics. NHS Health Research Authority.
![[E] Fifth Global Fund Cycle Modelling informing Global Fund strategy targets Report to the Board.pdf](/uploads/r/null/5/c/4/5c4cd9e19d7544a5eda2b278680063c001d49ec4b3870a25f51d5d4ffb559d53/e891430a-fb34-4d31-b427-4598d78af618-_E__Fifth_Global_Fund_Cycle_Modelling_informing_Global_Fund_strategy_targets_Report_to_the_Board_142.jpg)
[E] Fifth Global Fund Cycle Modelling informing Global Fund strategy targets Report to the Board.pdf
![[E] Extension of French vaccination mandates: from the recommendation of the Steering Committee of the Citizen Consultation on Vaccination to the law](/uploads/r/null/6/b/2/6b220ac5f7162e138027f28ec82f9426be48ea87ef5cd6c59621d941555ebf6a/9b89e49e-b0ca-4563-abeb-afe3c45cde25-_E__eurosurv-23-17-3_142.jpg)
[E] Extension of French vaccination mandates: from the recommendation of the Steering Committee of the Citizen Consultation on Vaccination to the law
![[E] Evonik press release on relocation of EAB to Tours](/uploads/r/null/c/9/9/c9917a78ebc9d8d06abb3168b0cd9394d5df60708e6e644e1e7e653d0d50f866/6ed835b2-b772-4cfe-bfec-f9c128550058-_E__evonik-opens-site-in-frances-cosmetic-valley-2020-11-30-15_11_51_142.jpg)
[E] Evonik press release on relocation of EAB to Tours
![[E] Evaluation of a national surveillance system for mortality alerts: a mixed-methods study](/uploads/r/null/b/5/e/b5e8b1a00883f65243627769220913278a1b5ca8e249fe138c6744173e61bc7c/5c528e5d-6a0c-4956-94a2-de6f61442eef-_E__Evalution_-_Report_142.jpg)
[E] Evaluation of a national surveillance system for mortality alerts: a mixed-methods study
![[E] EuReCa ONE-27 Nations, ONE Europe, ONE Registry: A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe](/uploads/r/null/5/6/5/565fe71b65bb4ea0e9d2a1350158256b2408021156489c6c5752607a4767cf7c/1d747052-410a-4d4e-9032-c5b5d43532a0-_E__EuReCa_Paper_142.jpg)
[E] EuReCa ONE-27 Nations, ONE Europe, ONE Registry: A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe